Literature DB >> 26091606

A Systematic Review of Research Guidelines in Decision-Analytic Modeling.

Maria Cristina Peñaloza Ramos1, Pelham Barton2, Sue Jowett1, Andrew John Sutton1.   

Abstract

BACKGROUND: Decision-analytic modeling (DAM) has been increasingly used to aid decision making in health care. The growing use of modeling in economic evaluations has led to increased scrutiny of the methods used.
OBJECTIVE: The objective of this study was to perform a systematic review to identify and critically assess good practice guidelines, with particular emphasis on contemporary developments.
METHODS: A systematic review of English language articles was undertaken to identify articles presenting guidance for good practice in DAM in the evaluation of health care. The inclusion criteria were articles providing guidance or criteria against which to assess good practice in DAM and studies providing criteria or elements for good practice in some areas of DAM. The review covered the period January 1990 to March 2014 and included the following electronic bibliographic databases: Cochrane Library, Cochrane Methodology Register and Health Technology Assessment, NHS Economic Evaluation Database, MEDLINE, and PubMed (Embase). Additional studies were identified by searching references.
RESULTS: Thirty-three articles were included in this review. A practical five-dimension framework was developed that describe the key elements of good research practice that should be considered and reported to increase the credibility of results obtained from DAM in the evaluation of health care.
CONCLUSIONS: This study is the first to critically review all available guidelines and statements of good practice in DAM since 2006. The development of good practice guidelines is an ongoing process, and important efforts have been made to identify what is good practice and to keep these guidelines up to date.
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Keywords:  decision-analytic modeling; good practice; guidelines; methods; modeling

Mesh:

Year:  2015        PMID: 26091606     DOI: 10.1016/j.jval.2014.12.014

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  16 in total

1.  How Qualitative Methods Can be Used to Inform Model Development.

Authors:  Samantha Husbands; Susan Jowett; Pelham Barton; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2017-06       Impact factor: 4.981

2.  Understanding and Identifying Key Issues with the Involvement of Clinicians in the Development of Decision-Analytic Model Structures: A Qualitative Study.

Authors:  Samantha Husbands; Susan Jowett; Pelham Barton; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2018-12       Impact factor: 4.981

Review 3.  Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy.

Authors:  Shigeo Fuji; Arnon Nagler; Mohamad Mohty; Bipin Savani; Roni Shouval
Journal:  Bone Marrow Transplant       Date:  2020-01-13       Impact factor: 5.483

Review 4.  Measures implemented in the school setting to contain the COVID-19 pandemic

Authors:  Shari Krishnaratne; Hannah Littlecott; Kerstin Sell; Jacob Burns; Julia E Rabe; Jan M Stratil; Tim Litwin; Clemens Kreutz; Michaela Coenen; Karin Geffert; Anna Helen Boger; Ani Movsisyan; Suzie Kratzer; Carmen Klinger; Katharina Wabnitz; Brigitte Strahwald; Ben Verboom; Eva Rehfuess; Renke L Biallas; Caroline Jung-Sievers; Stephan Voss; Lisa M Pfadenhauer
Journal:  Cochrane Database Syst Rev       Date:  2022-01-17

5.  The Use of Expert Elicitation among Computational Modeling Studies in Health Research: A Systematic Review.

Authors:  Christopher J Cadham; Marie Knoll; Luz María Sánchez-Romero; K Michael Cummings; Clifford E Douglas; Alex Liber; David Mendez; Rafael Meza; Ritesh Mistry; Aylin Sertkaya; Nargiz Travis; David T Levy
Journal:  Med Decis Making       Date:  2021-10-25       Impact factor: 2.749

6.  Reporting Guidelines for the Use of Expert Judgement in Model-Based Economic Evaluations.

Authors:  Cynthia P Iglesias; Alexander Thompson; Wolf H Rogowski; Katherine Payne
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

7.  GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence-An overview in the context of health decision-making.

Authors:  Jan L Brozek; Carlos Canelo-Aybar; Elie A Akl; James M Bowen; John Bucher; Weihsueh A Chiu; Mark Cronin; Benjamin Djulbegovic; Maicon Falavigna; Gordon H Guyatt; Ami A Gordon; Michele Hilton Boon; Raymond C W Hutubessy; Manuela A Joore; Vittal Katikireddi; Judy LaKind; Miranda Langendam; Veena Manja; Kristen Magnuson; Alexander G Mathioudakis; Joerg Meerpohl; Dominik Mertz; Roman Mezencev; Rebecca Morgan; Gian Paolo Morgano; Reem Mustafa; Martin O'Flaherty; Grace Patlewicz; John J Riva; Margarita Posso; Andrew Rooney; Paul M Schlosser; Lisa Schwartz; Ian Shemilt; Jean-Eric Tarride; Kristina A Thayer; Katya Tsaioun; Luke Vale; John Wambaugh; Jessica Wignall; Ashley Williams; Feng Xie; Yuan Zhang; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2020-09-24       Impact factor: 6.437

8.  Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation.

Authors:  Padraig Dixon; George Davey Smith; Stephanie von Hinke; Neil M Davies; William Hollingworth
Journal:  Pharmacoeconomics       Date:  2016-11       Impact factor: 4.981

Review 9.  Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer.

Authors:  Xavier Ghislain Léon Victor Pouwels; Bram L T Ramaekers; Manuela A Joore
Journal:  Breast Cancer Res Treat       Date:  2017-07-08       Impact factor: 4.872

10.  Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review.

Authors:  Guillaume Gingras; Marie-Hélène Guertin; Jean-François Laprise; Mélanie Drolet; Marc Brisson
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.